沙库巴曲缬沙坦起始治疗后的心脏逆向重构及预后 - Suppr

Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan.

作者信息

Januzzi James L, Camacho Alexander, Piña Ileana L, Rocha Ricardo, Williamson Kristin M, Maisel Alan S, Felker G Michael, Prescott Margaret F, Butler Javed, Solomon Scott D

机构信息

Massachusetts General Hospital, Boston, MA (J.L.J., A.C.).

Detroit Medical Center, MI (I.L.P.).

出版信息

Circ Heart Fail. 2020 Jun;13(6):e006946. doi: 10.1161/CIRCHEARTFAILURE.119.006946. Epub 2020 Jun 2.

DOI:10.1161/CIRCHEARTFAILURE.119.006946

PMID:32482089

Abstract

摘要

相似文献

Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan.沙库巴曲缬沙坦起始治疗后的心脏逆向重构及预后

Circ Heart Fail. 2020 Jun;13(6):e006946. doi: 10.1161/CIRCHEARTFAILURE.119.006946. Epub 2020 Jun 2.

Sacubitril/valsartan improves medium-term reverse left ventricular remodeling: why wait?沙库巴曲缬沙坦可改善中期左心室逆向重构：为何还要等待？

J Cardiovasc Med (Hagerstown). 2019 Oct;20(10):727-729. doi: 10.2459/JCM.0000000000000825.

Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review.沙库巴曲缬沙坦在真实世界实践中的应用：晚期心力衰竭患者的经验和系统评价。

Cardiovasc Drugs Ther. 2019 Jun;33(3):307-314. doi: 10.1007/s10557-019-06858-0.

Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?沙库巴曲缬沙坦治疗心力衰竭：是时候成为典范了吗？

J Cardiovasc Pharmacol. 2020 Feb;75(2):105-107. doi: 10.1097/FJC.0000000000000782.

In-Hospital Initiation of Sacubitril/Valsartan: A New PARADIGM for Acute Decompensated Heart Failure?沙库巴曲缬沙坦院内起始治疗：急性失代偿性心力衰竭的新范式？

J Cardiovasc Pharmacol. 2019 Jul;74(1):1-3. doi: 10.1097/FJC.0000000000000685.

Sacubitril/valsartan (Entresto) for heart failure.沙库巴曲缬沙坦（恩格列净）用于治疗心力衰竭。

Med Lett Drugs Ther. 2015 Aug 3;57(1474):107-9.

In heart failure with reduced ejection fraction patients' left ventricular global longitudinal strain is enhanced after 1-year therapy with sacubitril/valsartan compared with conventional therapy with angiotensin-converting enzyme-inhibitors or AT1 blockers: results from a retrospective cohort study.在射血分数降低的心力衰竭患者中，与使用血管紧张素转换酶抑制剂或AT1阻滞剂的传统治疗相比，使用沙库巴曲缬沙坦治疗1年后，左心室整体纵向应变增强：一项回顾性队列研究的结果。

J Cardiovasc Med (Hagerstown). 2019 Dec;20(12):857-858. doi: 10.2459/JCM.0000000000000851.

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation.血管紧张素受体脑啡肽酶抑制剂治疗功能性二尖瓣反流。

Circulation. 2019 Mar 12;139(11):1354-1365. doi: 10.1161/CIRCULATIONAHA.118.037077.

Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan.血管紧张素受体脑啡肽酶抑制剂用于射血分数降低的心力衰竭患者：来自台湾的真实世界经验

J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):152-157. doi: 10.1177/1074248419872958. Epub 2019 Sep 12.

Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan.接受沙库巴曲缬沙坦治疗的射血分数降低型心力衰竭退伍军人的特征和医疗保健利用情况。

Circ Heart Fail. 2019 Nov;12(11):e005691. doi: 10.1161/CIRCHEARTFAILURE.118.005691. Epub 2019 Nov 13.

引用本文的文献

The Feasibility of a Guideline-Directed Medical Therapy Rapid Up-Titration Programme Among Real-World Heart Failure Patients: A Multicentre Observational Study.真实世界中心力衰竭患者指南指导下的药物治疗快速滴定方案的可行性：一项多中心观察性研究

J Clin Med. 2025 May 21;14(10):3611. doi: 10.3390/jcm14103611.

Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者持续逆向重构的预测因素

ESC Heart Fail. 2025 Jun;12(3):2190-2199. doi: 10.1002/ehf2.15241. Epub 2025 Feb 10.

Real-world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure.沙库巴曲缬沙坦与单独使用肾素-血管紧张素系统（RAS）抑制剂在初发性心力衰竭患者中的真实世界比较疗效

ESC Heart Fail. 2025 Jun;12(3):1682-1692. doi: 10.1002/ehf2.15183. Epub 2025 Jan 30.

Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis.新冠疫情对德国心力衰竭新型指南导向药物治疗实施情况的影响：一项全国性回顾性分析

Lancet Reg Health Eur. 2023 Nov 7;35:100778. doi: 10.1016/j.lanepe.2023.100778. eCollection 2023 Dec.

The Rare Condition of Left Ventricular Non-Compaction and Reverse Remodeling.左心室心肌致密化不全与逆向重构的罕见病症

Life (Basel). 2023 Jun 3;13(6):1318. doi: 10.3390/life13061318.

Predicting left ventricular functional recovery in ischaemic cardiomyopathy: needs and challenges.预测缺血性心肌病患者左心室功能恢复：需求与挑战

Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B69-B74. doi: 10.1093/eurheartjsupp/suad071. eCollection 2023 Apr.

Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone.沙库巴曲缬沙坦与螺内酯联合治疗与血管紧张素转换酶抑制剂和螺内酯联合治疗相比，对早期左侧心脏逆向重构的评估

Front Cardiovasc Med. 2023 Apr 3;10:1103688. doi: 10.3389/fcvm.2023.1103688. eCollection 2023.

Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology.沙库巴曲缬沙坦治疗慢性心力衰竭患者左心室的逆向重构和功能改善：非缺血性与缺血性病因的比较

J Clin Med. 2023 Jan 12;12(2):621. doi: 10.3390/jcm12020621.

Effect of sacubitril/valsartan on natriuretic peptide in patients with compensated heart failure.沙库巴曲缬沙坦对心力衰竭代偿期患者利钠肽的影响。

Heart Vessels. 2023 Jun;38(6):773-784. doi: 10.1007/s00380-022-02230-9. Epub 2023 Jan 19.

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation.血管紧张素受体-中性肽链内切酶抑制剂对心房颤动时心房电不稳定性的影响。

Front Cardiovasc Med. 2022 Dec 8;9:1048077. doi: 10.3389/fcvm.2022.1048077. eCollection 2022.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献